High materiality7/10
Roivant Sciences price target raised to $41 from $34 at H.C. Wainwright
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright raises ROIV PT to $41 from $34; current price $35.12; gain 3.47.
- Wainwright raises ROIV PT to $41; current ~$35.12.
Key facts
- 01
Target: $41
- 02
Posted price: $35.12
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Douglas Tsao
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.